US EditionStudy for Subjects with Multiple Myeloma
Summary by Rush University Medical Center
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Study for Subjects with Multiple Myeloma
Study for Subjects with Multiple Myeloma abernotas Fri, 05/02/2025 - 10:23 Clinical Trial Study testing an experimental infusion called Ciltacabtagene autoleucel (cilta-cel) in people with multiple myeloma Rush University Medical Center NCT05346835 This study is testing an experimental infusion called Ciltacabtagene autoleucel (cilta-cel) and the purpose of this study is to find out if it is safe and effective in people with multiple myeloma.Cil…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
